Las Vegas, NV -- (SBWIRE) -- 10/25/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Washington Banking Co (NASDAQ:WBCO), Mast Therapeutics Inc (NYSEMKT: MSTX), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Pacific Biosciences of California (NASDAQ:PACB)
Washington Banking Co (NASDAQ:WBCO) managed to keep its gain at 19.30% on above-normal volume of 1.21M shares. The stock settled at $1.85 after floating in a range of $1.80 to $1.93. Its latest price has reached market capitalization of $158.18 million. Its 52-week range has been $1.40 to $2.74. Uranium Energy Corp. (Uranium Energy) is an exploration-stage company. It is a natural resource exploration company engaged in the exploration of properties in the United States.
Has WBCO Found The Bottom and Ready To Move Up? Find Out Here
Mast Therapeutics Inc (NYSEMKT: MSTX) traded down on a volume of 1.13 million, lower than its standard daily volume. Shares have dropped-2.60% to $0.502. Over the last twelve months, the stock has lost-30.4% and faced a worst price of $0.40. Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., is a development-stage company biopharmaceutical company focused on developing product candidates.
Has MSTX Found The Bottom And Ready To Gain Momentum? Find Out Here
Idera Pharmaceuticals Inc (NASDAQ:IDRA) settled 3.46% higher at $2.39 on below -normal volume of 1.14M shares during the last trading day. The stock has its 12-month high at $3.12 and 52-week low price was $0.19. It traded in a range of $2.31 to $2.50 during the last trading day. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates.
Why Should Investors Buy IDRA After the Recent Fall? Just Go Here and Find Out
In the last trading session, Pacific Biosciences of California (NASDAQ:PACB) was down on low volume, trading at a volume of 1.13M shares versus its average daily volume of 1.35 million shares. At $4.21, the stock has attained market capitalization of $274.70 million. Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States.
Why Should Investors Buy PACB After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)